CN Stock MarketDetailed Quotes

603168 Zhejiang Shapuaisi Pharmaceutical

Watchlist
  • 7.01
  • +0.11+1.59%
Market Closed Dec 27 15:00 CST
2.64BMarket Cap-31.02P/E (TTM)

Zhejiang Shapuaisi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Shapuaisi Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
122.55M
--
-22.06%
EPS
--
-0.01
--
--
Analyst Rating
Buy

Dec 27, 2024

Zhejiang Shapuaisi Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Zhejiang Shapuaisi Pharmaceutical Earnings Reports

  • Sharp Ace: Sharp Ace Report for the Third Quarter of 2024

    Oct 30 12:00 ET

  • Sharp Ace 2024 Third Quarter Report

    Oct 30 12:00 ET

  • Sharp Ace 2024 Semi-Annual Report

    Aug 30 12:00 ET

  • Sharp Ace 2024 Semi-Annual Report Summary

    Aug 30 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 27, 2024

    Buy

    • Strong Buy

      0.00%

    • Buy

      100.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Biomedical
    Biomedical
    Intraday+0.69%